Treatment of menorrhagia during menstruation: Randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid

British Medical Journal

Volumn 313, Issue 7057, 1996, Pages 579-582

  Bonnar, John ^a,b   Sheppard, Brian L ^a,b,c  

^a ST JAMES S HOSPITAL   (Ireland)

^b Pathology Research Laboratory   (Ireland)

^c Department of Human Reproduction ^*

Author keywords

[No Author keywords available]

Indexed keywords

ETAMSYLATE; MEFENAMIC ACID; TRANEXAMIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERUS BLEEDING;

EID: 0029810706     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7057.579     Document Type: Article

References (26)

1. Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health and Social Security. Morbidity statistics from general practice. London: HMSO, 1986.
2. Intercontinental Medical Statistics Ltd. United Kingdom and Ireland. London: IMS, 1994.
3. Smith SK. Hysterectomy - why and when? In: Smith SK, ed. Dysfunctional uterine bleeding. London: Royal Society of Medicine Press, 1994:107. (Key paper conferences, series 1.)
4. Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandins and dysfunctional uterine bleeding. Research and Clinical Forums 1983;5: 39-43.
5. Bonnar J, Sheppard BL, Dockeray CJ. The haemostatic system and dysfunctional uterine bleeding. Research and Clinical Forums 1983;5: 27-36.
6. Sheppard BL. The pathology of dysfunctional uterine bleeding. Clin Obstet Gynecol 1984;11:227-38.
7. Sheppard BL. The pathophysiology of dysfunctional uterine bleeding. In: Lowe J, Fox H, eds. Advances in gynaecological pathology. Edinburgh: Churchill Livingstone, 1992:191-206.
8. Nilsson L, Rybo G. Treatment of menorrhagia with an antifibrinolytic agent, tranexamic acid. Acta Obstet Gynecol Scand 1967;46:572-80.
9. Bonnar J, Guillebaud J, Kasonde JM, Sheppard BL. Clinical applications of fibrinolytic inhibition in gynaecology. J Clin Pathol 1980;33(suppl 14):55-9.
10. Anderson ABM, Haynes PJ, Guillebaud J, Turnbull AC. Reduction in menstrual blood loss by prostaglandin synthetase inhibitors. Lancet 1976;i:774-6.
11. Fraser IS, Pearse C, Shearmann RP, Elliott PM, McIpveen J, Mokham R. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstet Gynecol 1981;58:543-51.
12. Haynes PJ, Flint APF, Hodgson H, Anderson BM, Fray F, Turnbull AC. Studies in menorrhagia (a) mefenamic acid (b) endometrial prostaglandin concentrations. Int J Gynaecol Obstet 1980;17:567-72.
13. Harrison RF, Campbell S. A double-blind trial of ethamsylate in the treatment of primary and intra-uterine device menorrhagia. Lancet 1976;i:283-5.
14. Chamberlain G, Freeman R, Price F, Kennedy A, Green D, Eve L. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. Br J Obstet Gynaecol 1991;98: 707-10.
15. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 1964;16:244-8.
16. Hallberg L, Hogdahl A, Nilsson L, Rybo G. Menstrual blood loss - a population study. Acta Obstet Gynecol Scand 1966;45:320-51.
17. Dockeray CJ, Sheppard BL, Bonnar J. Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. Br J Obstet Gynaecol 1989;96:840-4.
18. Cameron IT, Haining R, Linsden M-A, Thomas VR, Smith SK. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstet Gynecol 1990;76:85-8.
19. Anderson ABM, Hagnes PJ, Guillebaud J, Turnbull AC. Reduction of menstrual blood loss by prostaglandin synthetase inhibitors. Lancet 1976;i:774-6.
20. Hall P, MacLachlin N, Thorn N. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid. Br J Obstet Gynaecol 1987;94:554-8.
21. Jaffe G, Wickham A. A double-blind pilot study of Dicynene in the control of menorrhagia. J Int Med Res 1973;1:127-9.
22. Haynes PJ, Anderson ABM, Turnbull AC. Patterns of menstrual blood loss in menorrhagia. Research and Clinical Forms 1979;1:73-8.
23. Haynes PJ, Hodgson H, Anderson ABM, Turnbull AC. Measurement of menstrual blood loss in patients complaining of menorrhagia. Br J Obstet Gynaecol 1977;84:763-8.
24. Cameron IT, Leusk R, Kelly RW, Baird DT. The effect of danazol, mefenamic acid, norethisterone and a progesterone impregnated coil on endometrial prostaglandin levels in women with menorrhagia. Prostaglandins 1988;34:99-110.
25. Preston JT, Cameron IT, Adams EJ, Smith SK. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol 1995;102:401-6.
26. Rybo G. Tranexamic acid therapy is effective treatment in heavy menstrual bleeding. Clinical Update on Safety Therapeutic Advances 1991;4:1-8.